Matrix metalloproteinases in cerebral vasospasm following aneurysmal subarachnoid hemorrhage

Neurology Research International

Volumn 2013, Issue , 2013, Pages

  Mehta, Vivek ^a   Russin, Jonathan ^a   Spirtos, Alexandra ^a   He, Shuhan ^a   Adamczyk, Peter ^a   Amar, Arun P ^a   Mack, William J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; COLLAGENASE 3; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MATRILYSIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTROPHIL COLLAGENASE; TRANSCRIPTION FACTOR ELK 1; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN VASOSPASM; DOPPLER FLOWMETRY; ENZYME ACTIVITY; HUMAN; INTRACRANIAL PRESSURE; MEAN ARTERIAL PRESSURE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANKIN SCALE; REVIEW; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; UPREGULATION;

EID: 84877288399     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2013/943761     Document Type: Review

References (38)

1. Feiler S., Plesnila N., Thal S. C., Zausinger S., Schöller K., Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage. Cerebrovascular Diseases 2011 32 3 289 295 10.1159/000328248
2. Broderick J. P., Brott T. G., Duldner J. E., Tomsick T., Leach A., Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 1994 25 7 1342 1347 2-s2.0-0028365713 (Pubitemid 24198577)
3. Dumont A. S., Dumont R. J., Chow M. M., Lin C. L., Calisaneller T., Ley K. F., Kassell N. F., Lee K. S., Barrow D. L., Macdonald R. L., Hoh B. L., Ogilvy C. S., Lawton M. T., Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003 53 1 123 135 2-s2.0-0038725119 (Pubitemid 36801515)
4. Kim S. C., Singh M., Huang J., Prestigiacomo C. J., Winfree C. J., Solomon R. A., Connolly E. S., Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery 1997 41 3 642 647 2-s2.0-0030824379 10.1097/00006123-199709000- 00027 (Pubitemid 27383202)
5. Yong V. W., Krekoski C. A., Forsyth P. A., Bell R., Edwards D. R., Matrix metalloproteinases and diseases of the CNS. Trends in Neurosciences 1998 21 2 75 80 2-s2.0-0031989284
6. McCawley L. J., Matrisian L. M., Matrix metalloproteinases: multifunctional contributors to tumor progression. Molecular Medicine Today 2000 6 4 149 156 2-s2.0-0034176764 10.1016/S1357-4310(00)01686-5 (Pubitemid 30171365)
7. Horstmann S., Su Y., Koziol J., Meyding-Lamadé U., Nagel S., Wagner S., MMP-2 and MMP-9 levels in peripheral blood after subarachnoid hemorrhage. Journal of the Neurological Sciences 2006 251 1-2 82 86 2-s2.0-33751249568 10.1016/j.jns.2006.09.005 (Pubitemid 44792144)
8. Galis Z. S., Kranzhöfer R., Fenton J. W., Libby P., Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 3 483 489 2-s2.0-0030896416 (Pubitemid 27133137)
9. Li Z., Li L., Zielke H. R., Cheng L., Xiao R., Crow M. T., Stetler-Stevenson W. G., Froehlich J., Lakatta E. G., Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. American Journal of Pathology 1996 148 1 121 128 2-s2.0-0030067790 (Pubitemid 26019650)
10. Galis Z. S., Sukhova G. K., Kranzhöfer R., Clark S., Libby P., Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proceedings of the National Academy of Sciences of the United States of America 1995 92 2 402 406 2-s2.0-0028836794 10.1073/pnas.92.2.402
11. Romanic A. M., Madri J. A., The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. Journal of Cell Biology 1994 125 5 1165 1178 2-s2.0-0028362088 10.1083/jcb.125.5.1165 (Pubitemid 24177218)
12. Menashi S., Lu H., Soria C., Legrand Y., Endothelial cell proteases: physiological role and regulation. Bailliere's Clinical Haematology 1993 6 3 559 576 2-s2.0-0027504658 10.1016/S0950-3536(05)80188-X (Pubitemid 23306580)
13. van Wart H. E., Birkedal-Hansen H., The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proceedings of the National Academy of Sciences of the United States of America 1990 87 14 5578 5582 2-s2.0-0025025442 10.1073/pnas.87.14.5578 (Pubitemid 20260224)
14. van den Steen P. E., Dubois B., Nelissen I., Rudd P. M., Dwek R. A., Opdenakker G., Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Critical Reviews in Biochemistry and Molecular Biology 2002 37 6 375 536 2-s2.0-0038059516 10.1080/10409230290771546 (Pubitemid 36071972)
15. Hayashita-Kinoh H., Kinoh H., Okada A., Komori K., Itoh Y., Chiba T., Kajita M., Yana I., Seiki M., Membrane-type 5 matrix metalloproteinase is expressed in differentiated neurons and regulates axonal growth. Cell Growth and Differentiation 2001 12 11 573 580 2-s2.0-0035189968 (Pubitemid 33095580)
16. Oh L. Y. S., Larsen P. H., Krekoski C. A., Edwards D. R., Donovan F., Werb Z., Yong V. W., Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligoclendrocytes. Journal of Neuroscience 1999 19 19 8464 8475 2-s2.0-0033215979 (Pubitemid 30226765)
17. Frölichsthal-Schoeller P., Vescovi A. L., Krekoski C. A., Murphy G., Edwards D. R., Forsyth P., Expression and modulation of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinases in human embryonic CNS stem cells. NeuroReport 1999 10 2 345 351 2-s2.0-0033524845 (Pubitemid 29104811)
18. Seeds N. W., Siconolfi L. B., Haffke S. P., Neuronal extracellular proteases facilitate cell migration, axonal growth, and pathfinding. Cell and Tissue Research 1997 290 2 367 370 2-s2.0-0030773748 10.1007/s004410050942 (Pubitemid 27470070)
19. Visse R., Nagase H., Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circulation Research 2003 92 8 827 839 2-s2.0-0037693895 10.1161/01.RES.0000070112.80711.3D (Pubitemid 36542523)
20. Brew K., Dinakarpandian D., Nagase H., Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochimica et Biophysica Acta 2000 1477 1-2 267 283 2-s2.0-0034615550 10.1016/S0167-4838(99)00279-4 (Pubitemid 30119906)
21. Chou S. H., Feske S. K., Simmons S. L., Konigsberg R. G. J., Orzell S. C., Marckmann A., Bourget G., Bauer D. J., De Jager P. L., Du R., Arai K., Lo E. H., Ning M. M., Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage. Translational Stroke Research 2011 2 4 600 607
22. Cuzner M. L., Opdenakker G., Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. Journal of Neuroimmunology 1999 94 1-2 1 14 2-s2.0-0033081796 10.1016/S0165-5728(98)00241-0 (Pubitemid 29071238)
23. Satoh M., Date I., Ohmoto T., Perkins E., Parent A. D., The expression and activation of matrix metalloproteinase-1 after subarachnoid haemorrhage in rats. Acta Neurochirurgica 2005 147 2 187 193 2-s2.0-12944254267 10.1007/s00701-004-0435-9 (Pubitemid 40174185)
24. Pins G. D., Collins-Pavao M. E., Van De Water L., Yarmush M. L., Morgan J. R., Plasmin triggers rapid contraction and degradation of fibroblast-populated collagen lattices. Journal of Investigative Dermatology 2000 114 4 647 653 2-s2.0-0033993710 10.1046/j.1523-1747.2000.00858.x (Pubitemid 30226995)
25. Scott K. A., Wood E. J., Karran E. H., A matrix metalloproteinase inhibitor which prevents fibroblast-mediated collagen lattice contraction. FEBS Letters 1998 441 1 137 140 2-s2.0-0032422922 10.1016/S0014-5793(98)01542-7 (Pubitemid 29012388)
26. Gaetani P., Rodriguez Y Baena R., Tartara F., Messina A. L., Tancioni F., Schiavo R., Grazioli V., Metalloproteases and intracranial vascular lesions. Neurological Research 1999 21 4 385 390 2-s2.0-0033033074 (Pubitemid 29297871)
27. Bruno G., Todor R., Lewis I., Chyatte D., Vascular extracellular matrix remodeling in cerebral aneurysms. Journal of Neurosurgery 1998 89 3 431 440 2-s2.0-0031721734 (Pubitemid 28405258)
28. Todor D. R., Lewis I., Bruno G., Chyatte D., Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2. Stroke 1998 29 8 1580 1583 2-s2.0-0031928271 (Pubitemid 28365577)
29. Horstmann S., Kalb P., Koziol J., Gardner H., Wagner S., Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies. Stroke 2003 34 9 2165 2170 2-s2.0-0041829250 10.1161/01.STR.0000088062.86084.F2 (Pubitemid 37099830)
30. McGirt M. J., Lynch J. R., Blessing R., Warner D. S., Friedman A. H., Laskowitz D. T., Lawton M. T., Awad I. A., Max Findlay J., Friedlander R. M., Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 2002 51 5 1128 1135 2-s2.0-0036871423 10.1097/00006123-200211000-00005 (Pubitemid 36322698)
31. Sehba F. A., Mostafa G., Knopman J., Friedrich V., Bederson J. B., Acute alterations in microvascular basal lamina after subarachnoid hemorrhage. Journal of Neurosurgery 2004 101 4 633 640 2-s2.0-7944234917 10.3171/jns.2004.101.4. 0633 (Pubitemid 43186422)
32. Bosman F. T., Cleutjens J., Beek C., Havenith M., Basement membrane heterogeneity. Histochemical Journal 1989 21 11 629 633 2-s2.0-0024457093 (Pubitemid 19277830)
33. Stanley J. R., Woodley D. T., Katz S. I., Martin G. R., Structure and function of basement membrane. Journal of Investigative Dermatology 1982 79 1 69s 72s 2-s2.0-0019968256 (Pubitemid 12080827)
34. Vikman P., Ansar S., Edvinsson L., Transcriptional regulation of inflammatory and extracellular matrix-regulating genes in cerebral arteries following experimental subarachnoid hemorrhage in rats: laboratory investigation. Journal of Neurosurgery 2007 107 5 1015 1022 2-s2.0-37149025398 10.3171/JNS-07/11/1015 (Pubitemid 350255217)
35. Guo Z., Sun X., He Z., Jiang Y., Zhang X., Role of matrix metalloproteinase-9 in apoptosis of hippocampal neurons in rats during early brain injury after subarachnoid hemorrhage. Neurological Sciences 2010 31 2 143 149 2-s2.0-77953540128 10.1007/s10072-009-0192-x
36. Wang Z., Fang Q., Dang B.-Q., Shen X.-M., Shu Z., Zuo G., He W.-C., Chen G., Potential contribution of matrix metalloproteinase-9 (mmp-9) to cerebral vasospasm after experimental subarachnoid hemorrhage in rats. Annals of Clinical & Laboratory Science 2012 42 1 14 20
37. Dittmar M., Kiourkenidis G., Horn M., Bollwein S., Bernhardt G., Cerebral ischemia, matrix metalloproteinases, and TNF-alpha: MMP inhibitors may act not exclusively by reducing MMP activity. Stroke 2004 35 7 e338 e340 2-s2.0-6044265706
38. Reijerkerk A., Kooij G., van der Pol S. M. A., Khazen S., Dijkstra C. D., de Vries H. E., Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB Journal 2006 20 14 E1901 E1909 2-s2.0-33845665284 10.1096/fj.06-6099fje (Pubitemid 44953777)